stage II mycosis fungoides/Sezary syndrome
Showing 1 - 25 of >10,000
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States
Recruiting
- Mycosis Fungoides
- +11 more
- Biospecimen Collection
- +5 more
-
Duarte, California
- +12 more
Jan 7, 2023
Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)
Recruiting
- Mycosis Fungoides
- +12 more
- Pembrolizumab
-
Jacksonville, FloridaMayo Clinic in Florida
Mar 22, 2022
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)
Active, not recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides/Sezary Syndrome
-
Madrid, Spain
- +1 more
Jul 1, 2022
Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Fungoides Mycosis Sezary Syndrome
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Jul 13, 2023
Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)
Active, not recruiting
- Mycosis Fungoides
- +2 more
- resminostat
- Placebo
-
Graz, Austria
- +53 more
Dec 12, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)
Not yet recruiting
- Mycosis Fungoides
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 13, 2023
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV
Recruiting
- Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
- +2 more
- Duvelisib
- +2 more
-
Phoenix, Arizona
- +11 more
Aug 6, 2022
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
-
Chicago, Illinois
- +2 more
Aug 30, 2021
Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15
Completed
- Adult T-Cell Lymphoma/Leukemia
- +2 more
- Recombinant human Interleukin-15 (rhIL-15)
- Mogamulizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)
Recruiting
- Mycosis Fungoides
- +2 more
- brentuximab vedotin
-
Stanford, California
- +7 more
Nov 3, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)
Recruiting
- Sezary Syndrome
- Mycosis Fungoides
- Mogamulizumab
- LD TSEBT
-
Stanford, CaliforniaStanford Cancer Center
Oct 19, 2022
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
-
Duarte, California
- +12 more
Jun 17, 2022
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the
Recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
- THERAKOS® CELLEX photopheresis system
-
New York, New YorkHerbert Irving Pavilion
Dec 23, 2022
Low-Dose Total Skin Electron Therapy in Treating Refractory or
Recruiting
- Recurrent Mycosis Fungoides
- +4 more
- Quality-of-Life Assessment
- Objective Grading of Skin Findings
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 5, 2022
Mapping Emotional Dynamics During Corticosteroid Treatment
Recruiting
- Emotions
- Corticosteroids
- Short daily questionnaire
-
Leiden, Zuid-Holland, NetherlandsLUMC
Aug 30, 2022
CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)
Recruiting
- CTCL
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2023
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
Not yet recruiting
- Cutaneous T Cell Lymphoma
- +2 more
-
Ancona, Italy
- +19 more
Nov 2, 2023
Patients With Mycosis Fungoides and Sézary Syndrome.
Recruiting
- Mycosis Fungoides
- Sezary Syndrome
- Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
-
Lund, SwedenLund University Hospital
May 21, 2021
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United
Recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Durvalumab
- +2 more
-
Duarte, California
- +3 more
Jan 12, 2023